Jane C Burns Selected Research

Interleukin-1 (Interleukin 1)

1/2022	Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles.
1/2017	Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.
9/2010	Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jane C Burns Research Topics

Disease

95	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 03/2024 - 02/2003
32	Aneurysm (Aneurysms) 10/2023 - 01/2007
25	Inflammation (Inflammations) 10/2023 - 05/2009
17	Fever (Fevers) 12/2021 - 10/2004
10	Vasculitis (Vasculitides) 01/2022 - 08/2004
8	COVID-19 01/2023 - 08/2021
7	COVID-19 related pediatric multisystem inflammatory disease 03/2024 - 01/2020
7	Heart Diseases (Heart Disease) 12/2023 - 10/2004
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 06/2005
5	Virus Diseases (Viral Diseases) 03/2024 - 01/2016
5	Infections 01/2019 - 01/2014
4	Thrombosis (Thrombus) 01/2021 - 11/2014
4	Rheumatic Fever (Acute Articular Rheumatism) 01/2008 - 06/2005
4	Endocarditis 01/2008 - 06/2005
3	Shock 10/2023 - 05/2009
3	Myocarditis (Carditis) 01/2023 - 01/2021
3	Autoimmune Diseases (Autoimmune Disease) 10/2022 - 01/2022
3	Fibrosis (Cirrhosis) 10/2021 - 12/2015
3	Bacteremia 01/2008 - 06/2007
2	Bacterial Infections (Bacterial Infection) 03/2024 - 08/2016
2	Pneumonia (Pneumonitis) 10/2022 - 03/2022
2	Communicable Diseases (Infectious Diseases) 01/2022 - 06/2005
2	Thrombocytopenia (Thrombopenia) 01/2022 - 08/2021
2	Cytokine Release Syndrome 01/2022 - 08/2021
2	Pathologic Constriction (Stenosis) 04/2016 - 04/2016
2	Heart Failure 04/2016 - 12/2015
2	Myocardial Infarction 04/2016 - 01/2016
2	Disease Progression 01/2013 - 09/2012
2	Disease Susceptibility (Diathesis) 01/2013 - 02/2011
1	Hemorrhage 12/2023
1	Thromboembolism 12/2023
1	Lymphadenopathy 10/2023
1	Rare Diseases (Rare Disease) 04/2023
1	Cardiomyopathies (Cardiomyopathy) 01/2023
1	Common Cold 01/2022
1	Lung Diseases (Lung Disease) 01/2022

Drug/Important Bio-Agent (IBA)

47	Intravenous Immunoglobulins (IVIG)FDA Link 10/2023 - 02/2003
13	Infliximab (Remicade)FDA Link 01/2022 - 05/2005
12	Biomarkers (Surrogate Marker)IBA 10/2021 - 05/2009
10	Proteins (Proteins, Gene)FDA Link 10/2023 - 12/2011
9	Peptides (Polypeptides)IBA 06/2022 - 12/2010
7	AntibodiesIBA 01/2023 - 01/2011
6	Immunoglobulin G (IgG)IBA 01/2023 - 01/2013
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 10/2004
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2015 - 02/2003
4	C-Reactive ProteinIBA 10/2023 - 05/2009
4	RNA (Ribonucleic Acid)IBA 06/2023 - 01/2013
4	VaccinesIBA 01/2023 - 06/2007
4	AntigensIBA 10/2022 - 01/2022
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 10/2004
4	Anti-Bacterial Agents (Antibiotics)IBA 08/2016 - 06/2007
4	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2015 - 02/2011
3	AutoantigensIBA 10/2022 - 01/2022
3	CytokinesIBA 01/2022 - 08/2021
3	Interleukin-1 (Interleukin 1)IBA 01/2022 - 09/2010
3	Atorvastatin (Lipitor)FDA Link 01/2022 - 01/2015
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 07/2008
3	Monoclonal AntibodiesIBA 12/2018 - 05/2005
3	CalciumIBA 10/2017 - 03/2012
3	Blood Proteins (Serum Proteins)IBA 01/2016 - 12/2010
3	AnticoagulantsIBA 11/2014 - 10/2004
3	gamma-Globulins (gamma-Globulin)IBA 05/2005 - 10/2004
2	TransferasesIBA 10/2023 - 01/2016
2	Immunoglobulin A (IgA)IBA 01/2023 - 01/2013
2	AutoantibodiesIBA 01/2023 - 01/2022
2	Neutralizing AntibodiesIBA 10/2022 - 01/2022
2	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 10/2022 - 03/2022
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2022
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022 - 01/2016
2	Interleukin-15 (Interleukin 15)IBA 01/2022 - 08/2021
2	LigandsIBA 01/2022 - 07/2005
2	Formaldehyde (Formol)FDA Link 01/2022 - 08/2021
2	SteroidsIBA 01/2020 - 09/2006
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 09/2012
2	MicroRNAs (MicroRNA)IBA 01/2017 - 01/2013
2	Phenobarbital (Luminal)FDA Link 04/2016 - 07/2015
2	Lipoproteins (Lipoprotein)IBA 01/2016 - 10/2014
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2016 - 01/2013
2	Immunoglobulins (Immunoglobulin)IBA 12/2015 - 05/2005
2	Matrix Metalloproteinases (MMPs)IBA 01/2014 - 12/2010
2	Abciximab (ReoPro)FDA Link 12/2004 - 10/2004
1	Cell-Free Nucleic AcidsIBA 03/2024
1	Factor Xa InhibitorsIBA 12/2023
1	Vitamin K FDA Link 12/2023
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2023
1	apixabanIBA 12/2023
1	BilirubinIBA 10/2023
1	Alanine Transaminase (SGPT)IBA 10/2023
1	GlucocorticoidsIBA 08/2023
1	Immunoglobulin M (IgM)IBA 01/2023
1	COVID-19 VaccinesIBA 01/2023

Therapy/Procedure

33	Therapeutics 10/2023 - 08/2004
4	Anesthesia 01/2008 - 06/2005
3	Resuscitation 01/2021 - 01/2020
3	Endarterectomy (Thromboendarterectomy) 12/2017 - 07/2015
2	Artificial Respiration (Mechanical Ventilation) 01/2021 - 01/2020
2	Aftercare (After-Treatment) 12/2018 - 05/2005
2	Critical Care (Surgical Intensive Care) 08/2016 - 06/2005
2	Physical Therapy Modalities (Physical Therapy Technique) 12/2004 - 10/2004
2	Retreatment 12/2004 - 10/2004